Purchase Order 36C24118P1756
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 awarded a $49,680 firm-fixed-price purchase order to Maxcyte, Inc., a for-profit organization, for an EXPERT ATX Electroporation System. The system will be used at the Columbia Healthcare VA System (WJB Dorn VA Medical Center) to support biomedical research, particularly in areas such as infectious disease research, regulatory missions, and advanced scientific investigations. The...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a commercial cell engineering company. The $24,200.00 contract is for the provision of MAXCYTE PROCESSING ASSEMBLIES. Maxcyte has previously held prime federal contracts with agencies like NIH, the Food and Drug Administration, and Department of Veterans Affairs to deliver specialized...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Maxcyte, Inc., a small business prime contractor, on June 16, 2020 for a "Scalable Transfection System." The contract has a ceiling value of $82,100 and a completion date of September 30, 2020. Maxcyte has previously provided specialized laboratory equipment and technologies, such as cell processing systems, electroporation, and scalable transfection systems, to federal agencies including...
- The U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $114,087.00 firm fixed-price purchase order to Maxcyte, Inc., a small business company, for the provision of an electroporator and scalable transfection system. This contract supports the FDA's biomedical research and regulatory missions, as Maxcyte has provided similar specialized laboratory equipment and technologies, such as cell processing systems, electroporation and scalable transfection...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Maxcyte, Inc., a small business, for the procurement of a MaxCyte ATX Scalable Transfection System with software licenses. The contract has a potential value of $50,069.70 and was awarded on March 18, 2019 with a completion date of June 2, 2019. The award was made on a sole-source basis under the...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Maxcyte, Inc. The contract is for the provision of an EXPERT STX SCALABLE TRANSFECTION SYSTEM, a specialized laboratory technology, to support the agency's biomedical research mission. The contract has a ceiling value of $107,300.00 and a period of performance through September 20, 2024. Maxcyte, Inc. is a...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a leading commercial cell engineering company, for the delivery of a PROCESSING ASSEMBLY, CL-1.1 3.5-ML (REAGENTS). The firm fixed price contract, with a potential value of $12,130.00, has an award date of February 15, 2019 and a completion date of April 19, 2019. There was no set-aside used for this contract...
- This is a $120,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Maxcyte, Inc., a commercial cell engineering company, to provide specialized laboratory equipment and technologies such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services to support NIDA's...
- This is a $31,160 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of a GENTLEMACS OCTO DISSOCIATOR. The award does not utilize any set-aside designation. Miltenyi Biotec is an experienced federal contractor, providing specialized laboratory equipment, reagents, and services to support biomedical research, cell therapy development, and clinical translation for government agencies...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA VISN 2) awarded a $130,166 firm fixed price purchase order to Molecular Devices LLC for a SPECTRAMAX ID5 SYSTEM WITH GRANT FUNDING. The place of performance is San Jose, California. The period of performance is from September 19, 2023 through September 5, 2024. This award will deliver a SPECTRAMAX ID5 system to support the VA's mission of providing healthcare services to veterans. As...
The Department of Veterans Affairs Veterans Health Administration awarded a $165,000.00 firm fixed price purchase order to Maxcyte, Inc., a leading commercial cell engineering company, for the provision of specialized laboratory equipment and technologies. This contract, which did not utilize a set-aside designation, is for the delivery of transfection systems to support the agency's biomedical research and clinical care missions. Through past prime federal contract awards, Maxcyte has provided similar specialized equipment and services, such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance, to agencies including the National Institutes of Health and the Food and Drug Administration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $165.0k | 6/25/18 |